Key Opinion Leader, Dr. Ralph DeFronzo presents the 'Future of Menin Inhibitors” and discusses icovamenib and its clinical results shared during WCIRDC 2025 in online interview SAN CARLOS, Calif., Dec ...

Researchers have discovered that the microbial metabolite TMA acts as a natural IRAK4 inhibitor, blocking inflammation and ...

The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

Discover how the gut metabolite TMA blocks inflammation and improves insulin sensitivity, offering new hope for diabetes ...

This paper aims to critique the argument constructed by Anna Smajdor and Joona Räsänen that pregnancy is a disease. Their argument that pregnancy fits the features of disease they enumerate stems from ...

Ghrelin is the “hunger hormone.” On binding with the ghrelin receptor, MK-677 stimulates the pituitary gland to release GH.

An international research team led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS together with Prof.